Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: The aiims experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 3, 2010, Pages 238-241

  Rath, Goura K ^a   Sharma, Daya N ^a   Julka, Parmod K ^a   Subramani, Vellaiyan ^a   Bahl, Amit ^a   Haresh, Kunhi P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Brachytherapy; Cervical carcinoma; Intracavitary radiotherapy; Pulsed doserate

Indexed keywords

CISPLATIN; COBALT 60;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRACHYTHERAPY; CARCINOMA; CISPLATIN; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDIA; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PARTICLE ACCELERATORS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77953348692     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181aaca5b     Document Type: Article

References (19)

1. Indian Council of Medical Research. Population Based Cancer Registry. New Delhi, India: Indian Council of Medical Research; 2001-2003.
2. Rath GK, Mohanti BK, eds. Textbook of Radiation Oncology-Principles and Practice. New Delhi, India: B.I. Churchil Livingstones; 2000.
3. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781-786.
4. Thomas GM. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol. 2000;10: 44-50.
5. Swift PS, Purser P, Roberts LW, et al. Pulsed low dose rate brachytherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 1997;37:811-817.
6. Bachtiary B, Dewitt A, Pintilie M, et al. Comparison of late toxicity between, continuous low dose rate and pulsed-dose-rate brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005;63:1077-1082.
7. Rogers L, Freel JH, Speiser LB. Pulsed-dose-rate brachytherapy for uterine cervix carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:95-100.
8. Chargari S, Magne N, Dumas I, et al. Physics contributions and clinical outcome with 3D-MRI based PDR intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2009;74:133-139.
9. Benedet JL, Bender H, Jones H III, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209-262.
10. Kaplan EL, Meier P. Nonparameteric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
12. Biswal BM, Mohanti BK, Rath GK, et al. Results of radical radiotherapy in carcinoma of the uterine cervix stages I-III. Clin Oncol. 1994;6:356-360.
13. Haustermans K, Fowler J, Landuyt W, et al. Is pulsed-dose-rate more damaging to spinal cord of rats than continuous low dose rate? Radiother Oncol. 1997;45:39-47.
14. De Brabandere M, Mousa AG, Nulens A, et al. Potential of dose optimization in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol. 2008;88:217-226.
15. Lindegaard JC, Tanderup K, Nielsen SK, et al. MRI-guided optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:756-764.
16. Koedooder K, van Wieringen, van Der Grient, et al. Safety aspect of pulsed-dose-rate brachytherapy: analysis of errors in 1300 treatment sessions. Int J Radiat Oncol Biol Phys. 2008;70:953-960.
17. Brener DJ, Schiff PB, Ang YH, et al. Pulsed-dose-rate brachytherapy: design of convenient (daytime) schedules. Int J Radiat Oncol Biol Phys. 1997;39: 809-815.
18. Sminia P, Schneider CJ, Geertjan van Tienhoven, et al. Office hours pulsed brachytherapy boost in breast cancer. Radiother Oncol. 2001;9:273-280.
19. Harms W, Krempien R, Grehn C, et al. Daytime pulsed-dose-rate brachytherapy as a new treatment option for previously irradiated patients with recurrent esophageal cancer. BJR. 2005;78:236-241.